QUANDRANTS

these guys are doing something right...

Long
QUANDRANTS Updated   
NASDAQ:ATHE   Alterity Therapeutics Limited
patent approvals, phases cleared, looks like a disruptive company doing good in the biotech space. 800 shares long, trading 1/2 the position around $2.50 today if it claws back up
Trade active:
target reached for the day but I'm long 1000 shares PT $2.70 near term, halving my position north of $3+. Setup looking good. Holding on this for awhile, likely buying additional dips.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.